Recombinant grass pollen — Competitive Intelligence Brief

Recombinant grass pollen (Recombinant grass pollen) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy. Area: Immunology / Allergy.

phase 3 Allergen immunotherapy Grass pollen allergens (recombinant) Immunology / Allergy Biologic

Target snapshot

Recombinant grass pollen (Recombinant grass pollen) — Allergopharma GmbH & Co. KG. Recombinant grass pollen allergen extract desensitizes the immune system to grass pollen by inducing immune tolerance through repeated controlled exposure.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Recombinant grass pollen TARGET	Recombinant grass pollen	Allergopharma GmbH & Co. KG	phase 3	Allergen immunotherapy	Grass pollen allergens (recombinant)
PURETHAL Birch, 20.000 AUM/ml	PURETHAL Birch, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Birch pollen allergens (Bet v 1 and related proteins)
ragweed pollen	ragweed pollen	The University of Texas Medical Branch, Galveston	marketed	Allergen immunotherapy
Allergovit Birch pollen	Allergovit Birch pollen	Royal Sussex County Hospital	marketed	Allergen immunotherapy
Routine continuous cluster of Alutard SQ	Routine continuous cluster of Alutard SQ	Beijing Tongren Hospital	marketed	Allergen immunotherapy (subcutaneous immunotherapy, SCIT)
House dust mite Novo Helisen Depot	House dust mite Novo Helisen Depot	Allergopharma GmbH & Co. KG	marketed	Allergen immunotherapy
GRASS 2800 BAU	GRASS 2800 BAU	Clinique Spécialisée en Allergies de la Capitale	marketed	Allergen immunotherapy extract	Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy class)

1. Allergopharma GmbH & Co. KG · 8 drugs in this class
2. HAL Allergy · 2 drugs in this class
3. Medical University of Silesia · 2 drugs in this class
4. ALK-Abelló A/S · 2 drugs in this class
5. Laboratorios Leti, S.L. · 1 drug in this class
6. National Taiwan University Hospital · 1 drug in this class
7. Royal Sussex County Hospital · 1 drug in this class
8. The University of Texas Medical Branch, Galveston · 1 drug in this class
9. University of Genova · 1 drug in this class
10. Anergis · 1 drug in this class